Policy
19 stories · United States edition

Healthcare Payment Integrity Initiatives Gain Momentum Across the USA
Efforts to tighten healthcare payment integrity are growing across the US, aiming to curb fraud and improve financial accountability.

US Health Insurers Widen Coverage for Digital Health Services
US insurers are now expanding coverage for digital health services, aiming to improve accessibility and reduce costs.

US Healthcare Organizations Bolster Vendor Risk Management Strategies
Healthcare providers in the US are enhancing vendor risk management to safeguard patient data and ensure compliance with federal regulations.

US Healthcare Leaders Tackle Workforce Challenges Ahead
As the US faces a healthcare workforce shortage, leaders are strategizing to meet future demands.

US Healthcare Providers Bolster Compliance with New Data Laws
US healthcare providers are enhancing compliance with recent data protection laws, raising the bar for privacy and security in patient data handling.

FDA Expedites Review of Innovative Cancer Therapies Boosting Hope
The FDA accelerates its review process for innovative cancer treatments, promising faster patient access.

Healthcare Mergers Slow Across the USA Amid Regulatory Scrutiny
Mergers in the US healthcare sector face delays as regulatory bodies intensify scrutiny to preserve competition and protect consumers.

US Healthcare Industry Faces Rising Demand for Compliance Experts
As regulations tighten, US healthcare systems increasingly seek compliance professionals to navigate complex requirements and ensure legal adherence.

US Employers Prepare for Another Year of Rising Healthcare Costs
US employers face escalating healthcare costs, affecting budgets and employee benefits in 2024.

The Crushing Impact of Medical Debt on Millions in the US
Medical debt remains a significant issue for millions of Americans, affecting access to healthcare and financial stability.

Rising Medicare Spending: Challenges of an Aging US Population
Medicare spending in the US is climbing as the population ages, posing financial and policy challenges.

US Regulators Clarify Legal Status of Peptides in Medicine
The FDA has issued new guidelines on the legal status of peptides, impacting their use in US medicine and research.
